OpenBilldrug price receipt

NADAC week of 2026-10-14

ICOSAPENT ETHYL 0.5 GM CAPSULE

For 30 capsules

Pharmacies pay

$10.03 filed

30 × $0.33423 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$43.11 filed

30 × $1.43703 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

4.3× estimated

Medicare paid 4.3× what pharmacies pay.

Part D averages every strength and form sold under “Icosapent Ethyl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$16.53 estimated

$10.03 + $1.50 (15%) + $5.00 fee per fill = $16.53

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ICOSAPENT ETHYL 0.5 GM CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as icosapent ethyl.

FDA gives its dosage form as capsule and its route as oral.

Its labelers, the companies named on the label, are Hikma Pharmaceuticals USA Inc., Camber Pharmaceuticals, Inc. and Dr. Reddy's Laboratories, Inc.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $10.03 for 30 capsules (30 × $0.33423 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 3 NDCs

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name icosapent ethyl with ICOSAPENT ETHYL 0.5 GM CAPSULE.

ProductPharmacies pay per unitMedicare per unit
ICOSAPENT ETHYL 0.5 GM CAPSULE this page
generic · capsule
$0.33423 per EA filed
eff. 2026-09-23
$1.43703 per EA filed
Part D 2024 average
ICOSAPENT ETHYL 1 GRAM CAPSULE
generic · capsule / capsule, liquid filled
$0.44081 per EA filed
eff. 2026-09-23
$1.43703 per EA filed
Part D 2024 average
ICOSAPENT ETHYL 500 MG CAPSULE
generic · capsule, liquid filled
$0.33423 per EA filed
eff. 2026-09-23
$1.43703 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $43.11 for 30 capsules, at an average of $1.43703 per EA in 2024 (2024-01-01 to 2024-12-31) for “Icosapent Ethyl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 555,547 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for ICOSAPENT ETHYL 0.5 GM CAPSULE labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Icosapent Ethyl / Icosapent Ethyl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.